Wegovy® is one of the most effective weight loss treatments available.
In clinical trials, individuals who used Wegovy alongside diet and exercise adjustments achieved an average weight loss of 14.9%, compared to just 2.4% in those who only made lifestyle changes without the medication.
Wegovy has also been shown to reduce the relative risk of certain cardiovascular events, such as non-fatal strokes, non-fatal heart attacks, and cardiovascular-related death, by up to 20%.
As a result, Wegovy has been approved in the UK for use in adults with an established cardiovascular condition to help lower the risk of further cardiovascular complications.